Responses
Clinical/translational cancer immunotherapy
Original research
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Compose a Response to This Article
Other responses
No responses have been published for this article.